Results 261 to 270 of about 11,608,610 (402)
OBSERVATIONS ON THE FUNCTIONAL HOMOGENEITY OF THE NEPHRON POPULATION IN THE CHRONICALLY DISEASED KIDNEY OF THE DOG* [PDF]
Neal S. Bricker+3 more
openalex +1 more source
Triblock copolymer‐reinforced liposomal mimics of extracellular vesicles are engineered with tunable membrane elasticity. A semi‐elastic formulation (Tri‐ARTEX8:2) co‐encapsulating stem cell cytosolic extract and AntagomiR155 targets inflamed joints via the ELVIS effect, reprograms macrophages from M1 to M2, and markedly alleviates collagen‐induced ...
Dahwun Kim+11 more
wiley +1 more source
Light Chain Distribution in Immune Deposits on Glomeruli of Kidneys in Human Renal Disease* [PDF]
Roger Herdman+3 more
openalex +1 more source
Multifunctional Biomedical Devices with Closed‐Loop Systems for Precision Therapy
This review explores two major types of closed‐loop therapeutic systems: self‐sustained and externally triggered. It highlights recent advances in stimuli‐responsive materials, integrated bioelectronics, and data‐driven control strategies, offering insight into emerging strategies for personalized, responsive drug delivery.
Yixuan Leng, Rujie Sun
wiley +1 more source
Cardiovascular disease in chronic kidney disease. [PDF]
Marx-Schütt K+5 more
europepmc +1 more source
The tubular hypothesis of nephron filtration and diabetic kidney disease
V. Vallon, S. Thomson
semanticscholar +1 more source
This review highlights recent progress in nanocarriers targeting pattern recognition receptors (PRRs), including Toll‐like and NOD‐like receptors, for enhancing the treatment of bacterial sepsis and related complications. These nanomedicines deliver antibiotics and anti‐inflammatory agents while modulating immune responses.
Eman A. Ismail+3 more
wiley +1 more source
An Inquiry into the Nature and Pathology of Granular Disease of the Kidney, and its Mode of Action in Producing Albuminous Urine [PDF]
openalex +1 more source
Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV‐1 Proviral DNA Excision
Advancements in ART improve HIV‐1 patient outcomes but are unable to eliminate latent viral DNA. To address this, CXCR4‐targeted lipid nanoparticles (T‐LNPs) for delivering CRISPR‐Cas9 to excise HIV‐1 DNA in infected cells are developed. These T‐LNPs achieve ≈60% HIV‐1 DNA excision efficacy in blood and splenic tissue, demonstrating promise for ...
Sudipta Panja+6 more
wiley +1 more source